Electrotransport delivery of nesiritide

A - Human Necessities – 61 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61N 1/30 (2006.01)

Patent

CA 2649393

The present invention provides methods and devices for the non-invasive, transdermal administration by electrotransport of nesiritide, or pharmaceutically acceptable nesiritide salts, to patients in need of treatment with nesiritide. The present invention also provides methods for the treatment of congestive heart failure that involve the administration of nesiritide, or pharmaceutically acceptable nesiritide salts, by electrotransport to patients that suffer from congestive heart failure.

La présente invention concerne des procédés et des dispositifs pour l'administration percutanée non invasive par transport électrique de nésiritide ou de sels de nésiritide pharmaceutiquement acceptables à des patients nécessitant un traitement au nésiritide. La présente invention concerne également des procédés de traitement de l'insuffisance cardiaque congestive qui impliquent l'administration de nésiritide ou de sels de nésiritide pharmaceutiquement acceptables par transport électrique à des patients atteints d'insuffisance cardiaque congestive.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Electrotransport delivery of nesiritide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Electrotransport delivery of nesiritide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Electrotransport delivery of nesiritide will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2011671

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.